113 related articles for article (PubMed ID: 2692058)
1. The effect of pyritinol upon P300 topography.
Maurer K; Dierks T; Ihl R
Psychiatry Res; 1989 Sep; 29(3):413-5. PubMed ID: 2692058
[No Abstract] [Full Text] [Related]
2. Psychopharmacological effects of pyritinol in normal volunteers.
Hindmarch I; Coleston DM; Kerr JS
Neuropsychobiology; 1990-1991; 24(3):159-64. PubMed ID: 2135070
[TBL] [Abstract][Full Text] [Related]
3. EEG brain mapping in gerontopsychopharmacology: on protective properties of pyritinol against hypoxic hypoxidosis.
Saletu B; Anderer P; Gruenberger J
Psychiatry Res; 1989 Sep; 29(3):387-90. PubMed ID: 2514439
[No Abstract] [Full Text] [Related]
4. Effects of pyritinol on the distribution of electrical brain activity.
Ihl R; Maurer K; Dierks T; Wannemacher W
Pharmacopsychiatry; 1988 Nov; 21(6):343-5. PubMed ID: 3244765
[No Abstract] [Full Text] [Related]
5. Pyritinol hydrochloride and cognitive functions: influence on children in slow learner classes.
Wälti U; Kuenzler M; Schild J; Vassella F; Pavlincova E; Bircher J; Herschkowitz N
Pediatr Res; 1975 Sep; 9(9):717-21. PubMed ID: 1105370
[TBL] [Abstract][Full Text] [Related]
6. [Specificity of the action of piracetam, encephabol and Cleregil on the transcallosal evoked potential].
Voronina TA; Krapivin SV; Nerobkova LN
Biull Eksp Biol Med; 1986 Mar; 101(3):320-2. PubMed ID: 3955218
[TBL] [Abstract][Full Text] [Related]
7. Hydergine treatment and psychophysiological measures in primary degenerative dementia.
Kuskowski MA; Morley G; Malone SM; Dysken MW; Okaya A
J Geriatr Psychiatry Neurol; 1990; 3(1):41-7. PubMed ID: 2189430
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological aspects of aging and gerontopsychopharmacology.
Saletu B
Mod Probl Pharmacopsychiatry; 1989; 23():43-55. PubMed ID: 2654613
[No Abstract] [Full Text] [Related]
9. [Experimental research on the effect of piracetam and pyritinol on the central nervous system].
Stroesco V; Gane P; Granici A; Constantinidi M
Physiologie; 1977; 14(3):165-72. PubMed ID: 411142
[No Abstract] [Full Text] [Related]
10. Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions.
Maurer K; Riederer P; Heinsen H; Beckmann H
Psychiatry Res; 1989 Sep; 29(3):391-3. PubMed ID: 2608799
[No Abstract] [Full Text] [Related]
11. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
Cooper AJ; Magnus RV
Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of pyritinol on sequelae of head injuries.
Kitamura K
J Int Med Res; 1981; 9(3):215-21. PubMed ID: 7016627
[TBL] [Abstract][Full Text] [Related]
13. Effects of some metabolites of pyritinol (Encephabol) on ACH release from brain slices.
Martin KJ; Tucker L; Widdowson L
Pharmacopsychiatry; 1988 Aug; 21 Suppl 1():33-6. PubMed ID: 3217429
[TBL] [Abstract][Full Text] [Related]
14. Effects of a cholinergic nootropic (WEB 1881 FU) on event-related potentials recorded in incidental and intentional memory tasks.
Münte TF; Heinze HJ; Scholz M; Künkel H
Neuropsychobiology; 1988; 19(3):158-68. PubMed ID: 3059222
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
16. [The influence of pyrithioxin on acute alcohol-contingent changes in the EEG, evoked potentials and behavior of cats].
Dolce G
Act Nerv Super (Praha); 1974 Mar; 16(1):42-4. PubMed ID: 4454935
[No Abstract] [Full Text] [Related]
17. Contribution to the search for vigilance-indicative EEG variables. Results of a controlled, double-blind study with pyritinol in elderly patients with symptoms of mental dysfunction.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Mar; 19(2):75-83. PubMed ID: 3517890
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
[TBL] [Abstract][Full Text] [Related]
19. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of temazepam in the EEGs of healthy volunteers.
Janssen FH; Beecher L; Griep PA; Declerck AC
Neuropsychobiology; 1989; 22(2):72-6. PubMed ID: 2577116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
